Your browser doesn't support javascript.
loading
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
Araujo-Fernandez, I; Delgado, J; Moscetti, L; Sarac, S B; Zander, H; Mueller-Egert, S; Dunder, K; Pean, E; Bergmann, L; Enzmann, H; Pignatti, F.
Affiliation
  • Araujo-Fernandez I; Oncology and Haematology Office, European Medicines Agency, Amsterdam, The Netherlands; Agence Nationale de Sécurité du Médicament et des Produits de Santé, Saint-Denis, France.
  • Delgado J; Oncology and Haematology Office, European Medicines Agency, Amsterdam, The Netherlands; Department of Haematology, Hospital Clinic, Barcelona, Spain. Electronic address: julio.delgado@ema.europa.eu.
  • Moscetti L; Oncology and Haematology Office, European Medicines Agency, Amsterdam, The Netherlands; Department of Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Sarac SB; Danish Medicines Agency, Copenhagen, Denmark; Committee for Medicinal Products for Human Use, EMA, Amsterdam, The Netherlands.
  • Zander H; Paul Ehrlich Institut, Langen, Germany.
  • Mueller-Egert S; Paul Ehrlich Institut, Langen, Germany.
  • Dunder K; Committee for Medicinal Products for Human Use, EMA, Amsterdam, The Netherlands; Lakemedelsverket, Uppsala, Sweden.
  • Pean E; Oncology and Haematology Office, European Medicines Agency, Amsterdam, The Netherlands.
  • Bergmann L; Universitatsklinikum Frankfurt, Frankfurt, Germany.
  • Enzmann H; Committee for Medicinal Products for Human Use, EMA, Amsterdam, The Netherlands; Bundesinstitut fur Arzneimittel und Medizinprodukte, Bonn, Germany.
  • Pignatti F; Oncology and Haematology Office, European Medicines Agency, Amsterdam, The Netherlands.
ESMO Open ; 6(1): 100008, 2021 02.
Article in En | MEDLINE | ID: mdl-33399074
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Reino Unido